Recombinant Mouse COMT Protein，His

Catechol-O-methyltransferase (COMT) is a pivotal enzyme involved in the metabolism of catecholamines, such as dopamine, epinephrine, and norepinephrine. Its role is crucial in regulating neurotransmitter levels, thus influencing various physiological and psychological processes, including mood, cognition, and stress response. COMT operates through the transfer of a methyl group from S-adenosylmethionine (SAM) to catechol compounds, rendering them less active and promoting their excretion. Genetic variations, particularly the COMT Val158Met polymorphism, have been linked to differential enzyme activity, impacting individual susceptibility to neuropsychiatric disorders, such as schizophrenia and depression. The study of recombinant COMT proteins has gained momentum in recent years, enabling researchers to investigate the structure-function relationships of the enzyme in detail, assess the effects of genetic variants, and discover potential therapeutic targets. By producing and characterizing recombinant forms of the enzyme, researchers can enhance our understanding of its catalytic mechanisms, develop inhibitors, and explore its role in various signaling pathways. Furthermore, recombinant COMT proteins provide valuable tools for studying the interaction of the enzyme with other proteins and small molecules, paving the way for innovative therapeutic strategies aimed at modulating catecholamine pathways in the treatment of mental health disorders. Overall, the exploration of COMT as a recombinant protein serves not only to elucidate its biochemical properties but also to advance our understanding of the neurobiological underpinnings of a range of psychiatric conditions.